LATIFY Phase III Trial Update: Ceralasertib + Imfinzi in Lung Cancer
0:09
LATIFY Phase III Trial Update: Ceralasertib + Imfinzi in Lung Can…
100 views4 months ago
YouTubeMCQ Pedia
*Did you know that DNA damage can become a powerful weapon against cancer?* In our latest blog, we explain how Ceralasertib, an ATR inhibitor, turns this damage into an advantage by reprogramming the tumor microenvironment and triggering a strong immune response that supercharges the effectiveness of immunotherapy. If you're curious about how science is transforming cancer treatment from the inside out, don’t miss this must-read. 👉 Check it out here: https://williamscancerinstitute.com/turning-
1:30
*Did you know that DNA damage can become a powerful weapon a…
189 views10 months ago
FacebookWilliams Cancer Institute
AstraZeneca PLC Announces Update on LATIFY Phase III trial of ceralasertib
AstraZeneca PLC Announces Update on LATIFY Phase III trial o…
5 months ago
marketscreener.com
Ceralasertib合成
34:57
Ceralasertib合成
2.4K viewsJan 11, 2023
bilibili郭二富贵
NEW HOPE FOR PATIENTS WITH INCURABLE CANCER: ADVANCES IN TREATMENT WITH CERALASERTIB https://williamscancerinstitute.com/new-hope-for-patients-with-incurable-cancer-advances-in-treatment-with-ceralasertib/ #cancerpatientsupport #Cancercare #cancercenter #stage4cancer #stage4cancer | Williams Cancer Institute
1:33
NEW HOPE FOR PATIENTS WITH INCURABLE CANCER: ADVANCE…
497 viewsApr 2, 2024
FacebookWilliams Cancer Institute
#45 Results of a phase II trial of olaparib in combination with ceralasertib in patients with recu
55:36
#45 Results of a phase II trial of olaparib in combination with ceral…
24 views5 months ago
YouTubeOsteosarcoma: MIB Agents Osteosarcoma Allia…
Thurrsday, we were joined by Katie Janeway, MD, MMSc and Suzanne Forrest, MD on OsteoBites to discuss, "Results of a phase II trial of olaparib in combination with ceralasertib in patients with recurrent and unresectable osteosarcoma". 🧬Watch the full episode here: https://www.youtube.com/watch?v=7Ch2PImEXeE 🧬Dr. Janeway received her MD and MMSc from Harvard Medical School. She completed her pediatrics residency and her Pediatric Hematology-Oncology fellowship at Boston Children’s Hospital and
3:10
Thurrsday, we were joined by Katie Janeway, MD, MMSc and Suzanne …
46 views5 months ago
FacebookMIB Agents Osteosarcoma Alliance
AstraZeneca Drug Combination Falls Short of Goal in Lung-Cance…
5 months ago
wsj.com
3:23
突破耐药屏障，颅内高效控制：色瑞替尼（Ceritinib）改写ALK阳性肺癌 …
1 month ago
bilibili抗癌驿站
Emerging Landscape of Oral SERD Giredestrant in mBC: acelERA & p…
15 views7 months ago
vumedi.com
18:04
Alisertib: A New Potential Standard for Overcoming Resistance in KR…
162 views1 month ago
YouTubeOncologyTube
1:16
New Oral SERD Elacestrant Shows Promise in ER+ Breast Cancer
78 views1 month ago
YouTubeThe Oncology Brief
13:51
Webinar: Ceraseal, Bioceramic Sealer (11, July 2020)
17.9K viewsJul 11, 2020
YouTubeMeta Biomed - Dental Department
20:37
SABCS 2021: Elacestrant, an oral selective estrogen receptor degra…
1.1K viewsMay 26, 2023
YouTubeSan Antonio Breast Cancer Symposium
Proactive management strategies for potential gastrointestinal adver…
Feb 25, 2016
nih.gov
18:05
考比替尼合成
755 viewsDec 1, 2022
bilibili郭二富贵
31:09
奥利司他合成
1.6K viewsNov 30, 2022
bilibili郭二富贵
26:07
Nazarov环化
625 viewsOct 22, 2022
bilibili郭二富贵
2:44
Ceritinib and Brain Metastases in NSCLC
371 viewsApr 22, 2015
YouTubeOncLive
7:07
#certolizumab | Uses, Dosage, Side Effects & Mechanism | Cimzia
991 viewsOct 31, 2023
YouTubeHe-InFo
7:29
CERAB vs Endografts Where Do We Stand - Rajesh K Malik, MD
1.8K viewsNov 17, 2021
YouTubeNY Endovascular Summit
41:32
Visual Exploration of the Evolving Role of Novel Oral SERDs and Mor…
173 views7 months ago
YouTubePeerView Oncology
0:46
Are Oral SERDs Better Than Standard Therapy in Breast Cancer?
116 views1 month ago
YouTubeCancerNetwork
3:01
FDA D.I.S.C.O. Burst Edition: FDA approval of Tecelra (afamitresgen…
311 viewsNov 18, 2024
YouTubeU.S. Food and Drug Administration
0:14
#CortesíaDeSertal | Un antiespasmódico, cómo Sertal, est…
291 viewsJan 24, 2024
FacebookMegalabs Centroamérica
Sequencing Endocrine and Targeted Therapies After CDK4/6 Inhibitor i…
4 weeks ago
onclive.com
2:19
肺结节一定要手术吗？国家癌症中心10年随访给出答案！KRAS基因靶 …
653 views5 months ago
bilibili癌度
Advanced HR BC: Elacestrant vs. ET, Alpelisib/Inavolisib for PIK3CA…
284 viewsMar 4, 2024
vumedi.com
17:11
EMERALD lead to the Elacestrant FDA Approval - OncBrothers in di…
1.2K viewsMay 18, 2023
YouTubeOncBrothers: Practice-Changing Cancer Discus…
7:35
Ribociclib and the Evolving Role of Oral SERDs in High-Risk Disease
1.3K views4 months ago
YouTubeOncUpdates: Latest Oncology Insights
See more videos
Static thumbnail place holder